ClinicalTrials.gg
Not yet recruitingNCT07905846Updated Oct 30, 2026

A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College Students

An interventional study of Online and Text Message Intervention in Alcohol and Cannabis, sponsored by The University of Texas at Arlington. Not yet recruiting. Open to participants aged 18 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by The University of Texas at Arlington · Not applicable, Interventional, and Prevention

Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
800
Allocation
Randomized
Ages
18 Years to 19 Years
Sex
All
01

Study summary

Building on promising pilot findings, this study will employ a Hybrid Type 1 Effectiveness-Implementation RCT to evaluate the effectiveness of a novel intervention for first-year college students who abstain from or use alcohol and cannabis lightly, compared to assessment-only control. Aim 1 will finalize the intervention through student feedback to ensure relevance and engagement and Aim 2 will test its impact on abstaining and light alcohol and cannabis use, related consequences, and key cognitive and behavioral outcomes in a two-arm RCT (N = 800) across the first semester and academic year. Aim 3 will assess early implementation outcomes using mixed methods, including focus groups with a Campus Advisory Board, validated survey measures, and intervention analytics, to inform future dissemination and implementation strategies.

02

Conditions studied

  • Alcohol
  • Cannabis

Keywords

  • college
  • prevention
  • alcohol
  • cannabis
03

In context

Lead sponsor

The University of Texas at Arlington is the lead sponsor of 39 studies on the registry; 12 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 2 (25%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: 1) 18-19 at the time of screening; 2) birthdate consistent with age; 3) first-year student at UTA; 4) no lifetime alcohol use or alcohol use in the past month limited to one day per week or less and never exceeding 4 drinks (women) or 5 drinks (men) on a single occasion at any point in their lifetime; 5) no lifetime cannabis use or cannabis use in the past month limited to one day per week or less and never exceeding that frequency at any point in their lifetime; 6) valid email; 7) valid mobile number with TM plan; and 8) no past or current treatment for alcohol or cannabis.

Exclusion Criteria: Exclusion criteria include not meeting inclusion criteria (see Inclusion Criteria above), unwillingness to participate, failure to provide consent (e.g., declining participation in the study), providing inconsistent responses (e.g., age) identified by the eligibility survey and introductory study telephone call, and having already participated in the study as identified by overlap or consistency in computer IP addresses, contact information, and demographics.

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
800 participants (estimated)

Study arms

  • Experimental
    Intervention Condition

    Participants in intervention group will receive a web-based personalized feedback intervention and 6 intervention text messages per week (2 text messages per day, 3 days per week) across 12 weeks (first semester of college).

    Behavioral: Online and Text Message Intervention

  • No intervention
    Assessment-only Control

Interventions

  • BehavioralOnline and Text Message Intervention

    Participants in the intervention condition will receive a brief web-based personalized feedback intervention, which will use participant data reported in the baseline assessment. Text message intervention content will fall into five categories informed by our prior formative work: (1) prototypes, (2) norms, (3) perceived vulnerability, (4) personal goals, and (5) substance-free activities. The intervention is designed to shift the emphasis from reducing heavy use to preventing initiation and escalation by incorporating content that supports students' existing decisions to maintain their abstinence or infrequent alcohol and cannabis use while supporting broader well-being through alternative activities, goal-setting, and peer connections.

06

What researchers measure

Primary outcomes

  1. Alcohol Initiation

    Alcohol initiation for those who abstain at baseline will be calculated as time-to-event from baseline date to the approximate date they first used alcohol.

    Time frame: From enrollment to 8 month follow-up

  2. Cannabis Initiation

    Cannabis initiation for those who abstain at baseline will be calculated as time-to-event from baseline date to the approximate date they first used cannabis

    Time frame: From enrollment to 8 month follow-up

  3. Alcohol Consumption

    Alcohol consumption will be assessed using the Daily Drinking Questionnaire, a validated self-report measure assessing the number of standard alcoholic drinks typically consumed on each day of the week, allowing calculation of typical weekly alcohol consumption and drinking frequency.

    Time frame: 4 and 8 month follow-up

  4. Cannabis Consumption

    Cannabis consumption will be assessed using a measure parallel to the Daily Drinking Questionnaire, and will assess the number of hours high on each day of the week, allowing calculation of typical cannabis use and frequency.

    Time frame: 4 and 8 month follow-up

07

Study locations

No study locations are listed for this record.

08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07905846
Lead sponsor
The University of Texas at Arlington
Responsible party
Dana Litt (Professor of Social Work, The University of Texas at Arlington) — Principal investigator
First posted
Oct 30, 2026
Start date
Sep 1, 2028 (estimated)
Primary completion
Jun 2030 (estimated)
Completion
Aug 2030 (estimated)
Last update
Oct 30, 2026

Study contacts

Dana Litt, PhD
Contact
starrlab@uta.edu
817-272-9822

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion